Literature DB >> 33681353

MiR-599 Protects Cardiomyocytes against Oxidative Stress-Induced Pyroptosis.

Xiaoying Fan1, Enbo Zhan1, Yuan Yao1, Ruoxi Zhang1, Yong Sun1, Xuefeng Tian2.   

Abstract

Oxidative stress is a crucial factor and key promoter of a variety of cardiovascular diseases associated with cardiomyocyte injury. Emerging literatures suggest that pyroptosis plays a key role in cardiac damages. However, whether pyroptosis contributes to cardiomyocyte injury under oxidative stress and the underlying molecular mechanisms are totally unclear. This study was designed to investigate the potential role of pyroptosis in H2O2-induced cardiomyocyte injury and to elucidate the potential mechanisms. Primary cardiomyocytes from neonatal Wistar rats were utilized. These myocytes were treated with different concentrations of H2O2 (25, 50, and 100 μM) for 24 h to induce oxidative injury. Our results indicated that mRNA and protein levels of ASC were remarkably upregulated and caspase-1 was activated. Moreover, the expressions of inflammatory factors IL-1β and IL-18 were also increased. Luciferase assay showed that miR-599 inhibited ASC expression through complementary binding with its 3'UTR. MiR-599 expression was substantially reduced in H2O2-treated cardiomyocytes. Upregulation of miR-599 inhibited cardiomyocyte pyroptosis under oxidative stress, and opposite results were found by decreasing the expression of miR-599. Consistently, miR-599 overexpression ameliorated cardiomyocyte injury caused by H2O2. Therefore, miR-599 could be a promising therapeutic approach for the management of cardiac injury under oxidative condition.
Copyright © 2021 Xiaoying Fan et al.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33681353      PMCID: PMC7906806          DOI: 10.1155/2021/3287053

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


  39 in total

1.  Identification a novel tumor-suppressive hsa-miR-599 regulates cells proliferation, migration and invasion by targeting oncogenic MYC in hepatocellular carcinoma.

Authors:  Jingjing Tian; Xibao Hu; Wei Gao; Jie Zhang; Ming Chen; Xinrong Zhang; Junhong Ma; Hongxia Yuan
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

2.  Activation of NADPH/ROS pathway contributes to angiogenesis through JNK signaling in brain endothelial cells.

Authors:  Zairan Wang; Jiping Yang; Jinchong Qi; Yonghui Jin; Liyan Tong
Journal:  Microvasc Res       Date:  2020-05-16       Impact factor: 3.514

3.  CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis.

Authors:  Ting Zhang; Yan Zhang; Mingyao Cui; Li Jin; Yimei Wang; Fengxiang Lv; Yuli Liu; Wen Zheng; Haibao Shang; Jun Zhang; Mao Zhang; Hongkun Wu; Jiaojiao Guo; Xiuqin Zhang; Xinli Hu; Chun-Mei Cao; Rui-Ping Xiao
Journal:  Nat Med       Date:  2016-01-04       Impact factor: 53.440

4.  Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death.

Authors:  Jianjin Shi; Yue Zhao; Kun Wang; Xuyan Shi; Yue Wang; Huanwei Huang; Yinghua Zhuang; Tao Cai; Fengchao Wang; Feng Shao
Journal:  Nature       Date:  2015-09-16       Impact factor: 49.962

5.  Upregulated thioredoxin and its reductase prevent H2O2-induced growth inhibition and death in human pulmonary artery smooth muscle cells.

Authors:  Woo Hyun Park
Journal:  Toxicol In Vitro       Date:  2019-07-03       Impact factor: 3.500

6.  T cell-intrinsic ASC critically promotes T(H)17-mediated experimental autoimmune encephalomyelitis.

Authors:  Bradley N Martin; Chenhui Wang; Cun-jin Zhang; Zizhen Kang; Muhammet Fatih Gulen; Jarod A Zepp; Junjie Zhao; Guanglin Bian; Jeong-su Do; Booki Min; Paul G Pavicic; Caroline El-Sanadi; Paul L Fox; Aoi Akitsu; Yoichiro Iwakura; Anasuya Sarkar; Mark D Wewers; William J Kaiser; Edward S Mocarski; Marc E Rothenberg; Amy G Hise; George R Dubyak; Richard M Ransohoff; Xiaoxia Li
Journal:  Nat Immunol       Date:  2016-03-21       Impact factor: 25.606

7.  Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism.

Authors:  Juan Valle Raleigh; Adolfo G Mauro; Teja Devarakonda; Carlo Marchetti; Jun He; Erica Kim; Scott Filippone; Anindita Das; Stefano Toldo; Antonio Abbate; Fadi N Salloum
Journal:  Cardiovasc Res       Date:  2017-05-01       Impact factor: 10.787

8.  The PYRIN domain-only protein POP2 inhibits inflammasome priming and activation.

Authors:  Rojo A Ratsimandresy; Lan H Chu; Sonal Khare; Lucia de Almeida; Anu Gangopadhyay; Mohanalaxmi Indramohan; Alexander V Misharin; David R Greaves; Harris Perlman; Andrea Dorfleutner; Christian Stehlik
Journal:  Nat Commun       Date:  2017-06-05       Impact factor: 14.919

9.  miR-599 Inhibits Vascular Smooth Muscle Cells Proliferation and Migration by Targeting TGFB2.

Authors:  Baodong Xie; Chunfeng Zhang; Kai Kang; Shulin Jiang
Journal:  PLoS One       Date:  2015-11-09       Impact factor: 3.240

10.  Ferulic acid (FA) protects human retinal pigment epithelial cells from H2 O2 -induced oxidative injuries.

Authors:  Kunpeng Xie; Bo Jin; Haiyan Zhu; Pengyi Zhou; Liping Du; Xuemin Jin
Journal:  J Cell Mol Med       Date:  2020-10-20       Impact factor: 5.295

View more
  3 in total

1.  miR-1183 Is a Key Marker of Remodeling upon Stretch and Tachycardia in Human Myocardium.

Authors:  Natasa Djalinac; Ewald Kolesnik; Heinrich Maechler; Susanne Scheruebel-Posch; Brigitte Pelzmann; Peter P Rainer; Ines Foessl; Markus Wallner; Daniel Scherr; Akos Heinemann; Simon Sedej; Senka Ljubojevic-Holzer; Dirk von Lewinski; Egbert Bisping
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

2.  Nrf2 Inhibits the Progression of Parkinson's Disease by Upregulating AABR07032261.5 to Repress Pyroptosis.

Authors:  Yunxiao Zhong; Xiaodong Cai; Li Ding; Jinchi Liao; Xu Liu; Yiying Huang; Xiaohong Chen; Ling Long
Journal:  J Inflamm Res       Date:  2022-02-02

Review 3.  Non-coding RNAs in necroptosis, pyroptosis, and ferroptosis in cardiovascular diseases.

Authors:  Yuxi Cai; Yiwen Zhou; Zhangwang Li; Panpan Xia; Xinxi ChenFu; Ao Shi; Jing Zhang; Peng Yu
Journal:  Front Cardiovasc Med       Date:  2022-08-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.